AccuStem Sciences, Inc.
ACUT
$0.98
$0.09410.61%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 18.64% | 26.60% | 50.45% | 46.52% | 53.98% |
| Total Depreciation and Amortization | -16.67% | 0.00% | 0.00% | 0.00% | 2.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 441.50% | 286.01% | -29.20% | -39.12% | -50.66% |
| Change in Net Operating Assets | 20.47% | 51.40% | -53.15% | -41.05% | -74.19% |
| Cash from Operations | 49.04% | 58.89% | 50.62% | 49.07% | 46.39% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -44.54% | -37.35% | 23.36% | 160.15% | -- |
| Total Debt Repaid | 64.67% | 61.19% | 19.00% | -15.92% | 34.45% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -39.79% | -28.28% | 35.74% | 256.65% | 382.68% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 115.77% | 97.70% | 97.31% | 96.00% | 94.41% |